Literature DB >> 15737318

[Endoscopic thyroidectomy. A preliminary report including 40 patients].

P Cougard1, L Osmak, P Esquis, P Ognois.   

Abstract

AIM OF THE STUDY: To demonstrate the feasibility of endoscopic thyroidectomy for unilateral lobectomy and isthmectomy.
MATERIAL AND METHODS: [corrected] This prospective study included 40 patients operated on between January 1999 and March 2005 by a total endoscopic approach. Only lobectomies and isthmectomies were performed for nodules inferior to 3 cm in diameter.
RESULTS: Forty patients (36 females, 4 males) underwent 35 lobectomies and five isthmectomies. Twenty-four patients were operated on without ultrasonic shears (US) the rate of conversion in this group was 33%. Sixteen patients were operated on with US: the rate of conversion was 0%. In the second group, the operative time was decreasing to the half, range 45 to 90 minutes. In both the two groups, there were no morbidity: no extensive emphysema, no hematoma, no wound abscess, no cord vocal palsy. The median hospital stay was 1,75 days. After three months of follow up, all the patients were satisfied, especially concerning the cosmetic results and the short recovery time.
CONCLUSIONS: Endoscopic thyroidectomy is feasible and safe for performing lobectomies and isthmectomies. In the near future, it could be extended to bilateral goitres in selected patients.

Entities:  

Mesh:

Year:  2005        PMID: 15737318     DOI: 10.1016/j.anchir.2005.01.001

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  14 in total

1.  The axillary access in unilateral thyroid resection.

Authors:  Kai Witzel
Journal:  Langenbecks Arch Surg       Date:  2007-01-19       Impact factor: 3.445

Review 2.  Thyroid surgery: postoperative hematoma--prevention and treatment.

Authors:  Jane Harding; Frederic Sebag; Mauricio Sierra; F Fausto Palazzo; Jean-François Henry
Journal:  Langenbecks Arch Surg       Date:  2006-03-23       Impact factor: 3.445

3.  The operation experience of endoscopic thyroidectomy by areola and axilla approach.

Authors:  Lai-Yang Xia; Chun He; Xing-Wei Huang; Xun Xi; Xue-Kui Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-06       Impact factor: 2.503

4.  Evaluation of postoperative pain after minimally invasive video-assisted and conventional thyroidectomy: results of a prospective study. ESES Vienna presentation.

Authors:  Pier Francesco Alesina; Thomas Rolfs; Katrin Rühland; Violetta Brunkhorst; Harald Groeben; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2010-07-14       Impact factor: 3.445

5.  Minimally invasive supraomohyoid neck dissection by total endoscopic technique for oral squamous carcinoma.

Authors:  Ravindrasinh Raj; Vikram Lotwala; Piyush Anajwala
Journal:  Surg Endosc       Date:  2015-12-29       Impact factor: 4.584

6.  [Transoral partial parathyroidectomy].

Authors:  E Karakas; T Steinfeldt; A Gockel; A Sesterhenn; D K Bartsch
Journal:  Chirurg       Date:  2010-11       Impact factor: 0.955

7.  Transoral access for endoscopic thyroid resection.

Authors:  K Witzel; B H A von Rahden; C Kaminski; H J Stein
Journal:  Surg Endosc       Date:  2007-12-28       Impact factor: 4.584

8.  Endoscopic Thyroid Surgery Through Trans-oral Vestibular Approach (TOVA): A Case Series and Review of Literature.

Authors:  Gyan Chand; Goonj Johri; S K Mishra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-08-10

9.  Transoral thyroid and parathyroid surgery.

Authors:  Elias Karakas; Thorsten Steinfeldt; Andreas Gockel; Reiner Westermann; Anja Kiefer; Detlef K Bartsch
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

10.  Trans-Oral Video-Assisted Neck Surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach.

Authors:  Akihiro Nakajo; Hideo Arima; Munetsugu Hirata; Tadao Mizoguchi; Yuko Kijima; Shinichiro Mori; Sumiya Ishigami; Shinichi Ueno; Heiji Yoshinaka; Shoji Natsugoe
Journal:  Surg Endosc       Date:  2012-11-21       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.